```html

Pancreatic Pseudocyst – A Complete Patient Guide

Overview

A pancreatic pseudocyst is a fluid‑filled sac that forms in or near the pancreas, usually after an episode of acute pancreatitis, chronic pancreatitis, or pancreatic trauma. Unlike true cysts, pseudocysts lack an epithelial lining; instead, they are surrounded by a wall of fibrous tissue and granulation cells.

Who it affects: Adults between 30–60 years of age are most commonly affected, with a slight male predominance (≈ 55 %). The condition is rare in children, but can occur after traumatic injury to the pancreas.

Prevalence: Approximately 5–15 % of patients with acute pancreatitis and up to 30 % of those with chronic pancreatitis develop a pseudocyst at some point in their disease course. In the United States, an estimated 3–5 cases per 100,000 people are diagnosed each year.<sup>1</sup>

Symptoms

Symptoms vary widely depending on the size, location, and whether the cyst is compressing nearby structures. Common presentations include:

• Abdominal pain – dull, aching or cramping pain in the upper abdomen, often radiating to the back. Pain may worsen after meals.
• Early satiety & loss of appetite – the cyst can press on the stomach, making you feel full quickly.
• Nausea & vomiting – especially if the cyst obstructs the duodenum.
• Weight loss – due to reduced intake and malabsorption.
• Jaundice – yellowing of skin and eyes if the cyst compresses the common bile duct.
• Palpable mass – a soft, fluid‑filled lump may be felt in the upper abdomen.
• Fever & chills – suggest infection of the cyst (called an infected pseudocyst).
• Elevated heart rate, low blood pressure – signs of internal bleeding if the cyst ruptures.

Small pseudocysts (< 3 cm) often cause no symptoms and are discovered incidentally on imaging studies.

Causes and Risk Factors

Primary Causes

• Acute pancreatitis – most pseudocysts develop 4–6 weeks after an acute inflammatory episode.
• Chronic pancreatitis – repeated inflammation leads to ductal strictures and fluid collection.
• Pancreatic trauma – blunt or penetrating injuries in a motor‑vehicle accident or surgery.
• Pancreatic duct obstruction – caused by gallstones, tumors, or strictures.

Risk Factors

• Heavy alcohol use (≥ 3 drinks/day) – responsible for up to 70 % of chronic pancreatitis cases.
• Gallstone disease – the second most common cause of acute pancreatitis.
• Hypertriglyceridemia (triglycerides > 1000 mg/dL).
• Genetic predisposition (e.g., PRSS1, SPINK1 mutations).
• Smoking – doubles the risk of chronic pancreatitis.
• Obesity – associated with more severe pancreatitis and thus higher cyst risk.

Diagnosis

Diagnosis requires a combination of clinical suspicion, imaging, and laboratory studies.

Imaging Tests

• Transabdominal Ultrasound – first‑line, inexpensive, can detect fluid collections > 2 cm.
• Contrast‑enhanced CT Scan – gold standard; defines size, wall thickness, and relationship to nearby organs. Sensitivity > 90 %.
• Magnetic Resonance Cholangiopancreatography (MRCP) – non‑invasive way to visualize the pancreatic duct and differentiate pseudocysts from true cystic neoplasms.
• Endoscopic Ultrasound (EUS) – provides high‑resolution images and allows fine‑needle aspiration (FNA) if infection or malignancy is suspected.

Laboratory Tests

• Serum amylase and lipase – may be mildly elevated but are not diagnostic.
• Complete blood count – leukocytosis suggests infection.
• Serum albumin and electrolytes – assess nutritional status.
• Cytology of aspirated fluid (if FNA performed) – helps rule out cystic tumors.

Diagnostic Criteria (International Consensus)

1. Fluid collection persisting > 4 weeks after pancreatitis.
2. Encapsulated wall visible on cross‑sectional imaging.
3. No solid components or septations that would suggest a cystic neoplasm.

Treatment Options

Treatment is individualized based on cyst size, symptoms, and complications.

Observation

• Asymptomatic cysts < 6 cm may be observed with repeat imaging every 6–12 months.
• Patients are advised to avoid alcohol and maintain good nutritional status.

Medical Management

• Pain control – acetaminophen, low‑dose NSAIDs, or opioids for breakthrough pain.
• Pancreatic enzyme supplementation – improves digestion and reduces abdominal pain.
• Proton‑pump inhibitors – reduce gastric acidity that can exacerbate pain.
• Antibiotics – reserved for confirmed infection (e.g., ciprofloxacin + metronidazole).

Interventional Procedures

1. Endoscopic Drainage (EUS‑guided) – creates a fistula between the cyst and the stomach or duodenum; highly effective for cysts 6–10 cm.
2. Percutaneous Catheter Drainage – image‑guided placement of a tube through the abdominal wall; useful for superficial cysts or when endoscopy is not feasible.
3. Surgical Drainage – options include cystogastrostomy, cystojejunostomy, or distal pancreatectomy; indicated for large (> 10 cm), multiloculated, or recurrent cysts.

When Intervention Is Recommended

• Cyst ≥ 6 cm and symptomatic.
• Rapid growth (> 1 cm in 2 months).
• Complications: infection, bleeding, rupture, biliary obstruction, or gastric outlet obstruction.

Living with Pancreatic Pseudocyst

Nutrition

• Eat small, frequent meals low in fat (≤ 30 % of total calories).
• Include high‑protein foods (lean poultry, fish, tofu) to support healing.
• Consider pancreatic enzyme replacement (e.g., Creon) with each main meal.
• Stay hydrated – aim for 2–3 L of water daily unless fluid restriction is advised.

Lifestyle Adjustments

• Alcohol abstinence – eliminates a major trigger for recurrence.
• Smoking cessation – improves pancreatic blood flow.
• Maintain a healthy weight (BMI 18.5–24.9) to reduce stress on the pancreas.
• Gentle physical activity (walking, swimming) improves overall wellbeing, but avoid heavy lifting that raises intra‑abdominal pressure during the acute phase.

Monitoring

• Schedule follow‑up imaging (CT or MRI) as advised—usually every 6 months for the first 2 years.
• Track symptoms in a diary; note any new pain, fever, or changes in appetite.
• Regular blood work to monitor pancreatic enzymes, liver function, and nutritional markers.

Emotional Health

Living with a chronic pancreatic condition can cause anxiety or depression. Consider counseling, support groups, or psychotherapy. Resources such as the American Pancreatic Association patient forum can be valuable.

Prevention

• Control underlying pancreatitis – manage gallstones (cholecystectomy when indicated), keep triglycerides < 500 mg/dL, and treat autoimmune causes promptly.
• Alcohol moderation – follow CDC guidelines (≤ 2 drinks/day for men, ≤ 1 drink/day for women) or abstain entirely if you have pancreatitis.
• Quit smoking – use nicotine replacement or prescription aids if needed.
• Adopt a balanced diet rich in fruits, vegetables, whole grains, and lean proteins.
• Regular medical check‑ups for patients with known chronic pancreatitis to detect cysts early.

Complications

If left untreated, pancreatic pseudocysts can lead to serious outcomes:

• Infection (abscess) – presents with fever, leukocytosis, and worsening pain.
• Hemorrhage – erosion into nearby vessels (splenic artery, gastroduodenal artery) can cause massive intra‑abdominal bleeding.
• Rupture – sudden release of cyst contents into the peritoneal cavity leads to peritonitis.
• Biliary obstruction – jaundice, dark urine, and pruritus.
• Gastric outlet obstruction – vomiting and inability to tolerate oral intake.
• Pancreatic fistula formation – abnormal connection to the bowel or skin.
• Malignancy masking – rare cystic neoplasms can mimic pseudocysts; delayed diagnosis may affect cancer outcomes.

When to Seek Emergency Care

References

1. American College of Gastroenterology. “Management of Pancreatic Pseudocysts.” Gastroenterology, 2022.
2. Mayo Clinic. “Pancreatic cysts: Types, symptoms, and treatment.” Updated 2023.
3. CDC. “Alcohol Use and Its Effects on Pancreatitis.” 2021.
4. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Pancreatitis.” 2022.
5. World Health Organization. “Global incidence of pancreatitis and related complications.” 2020.

```